Back
Syndax Pharmaceuticals 10K Form
Sell
30
SNDX
Syndax Pharmaceuticals
Last Price:
12.99
Seasonality Move:
15.76%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
| 2023-08-03 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
| 2023-05-08 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
| 2022-08-08 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
| 2022-05-09 | 10Q | SNDX/Syndax Pharmaceuticals Quarterly |
Receive SNDX News And Ratings
See the #1 stock for the next 7 days that we like better than SNDX
SNDX Financial Statistics
Sales & Book Value
| Annual Sales: | $139.71M |
|---|---|
| Cash Flow: | $-62.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.30 |
| Price / Book: | 3.18 |
Profitability
| EPS (TTM): | -3.63000 |
|---|---|
| Net Income (TTM): | $-297.06M |
| Gross Margin: | $0 |
| Return on Equity: | -67.33% |
| Return on Assets: | -60.43% |
Syndax Pharmaceuticals Earnings Forecast
Key Syndax Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for SNDX have been equal to 18.07% of Gross Profit Margin.
- The Interest Expense is -0.10% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 5 years.
Syndax Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SNDX |
| CUSIP: | 87164F |
| Website: | syndax.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.99 |
| Quick Ratio: | 6.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SNDX Technical Analysis vs Fundamental Analysis
Sell
30
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy or a Sell?
-
Syndax Pharmaceuticals stock is rated a Sell
The current Syndax Pharmaceuticals [SNDX] share price is $13.24. The Score for SNDX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.